Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
Status:
Terminated
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate superiority of Fluticasone/Formoterol
(Flutiform®) to Fluticasone/salmeterol based on the small airway function by assessing the
Impulse Oscillometic System (IOS) in uncontrolled asthma patients requiring ICS/LABA
concomitant treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Korea Ltd
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Formoterol Fumarate Salmeterol Xinafoate Xhance